We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

New late-stage study data shows that treatment with Amgen's Uplizna for a year improves disease symptoms in patients with ...

The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...

The phase 3 MINT trial evaluated the efficacy and safety of the drug in both muscle-specific kinase autoantibody ...

After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...

Three-time Major Champion Pádraig Harrington and PGA TOUR winner Séamus Power have confirmed they will be joining Rory McIlroy and Shane Lowry at the 2025 Amgen Irish Open.

Rory McIlroy needs to win The Masters to complete the career Grand Slam, having won the last of his four major titles at the ...

Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...

Low socioeconomic status, chronic conditions, and inconsistent insurance coverage are linked to unhealthy aging trajectories in middle-aged US adults, shows a recent study.

In the latest trading session, Amgen (AMGN) closed at $317.17, marking a +1.1% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.64%. Meanwhile, the Dow experienced a rise ...